Phenobarbital Pharmacology Podcast

Phenobarbital, an older barbiturate used for seizure control, functions by depressing central nervous system activity. Clinical management requires strict adherence to three primary boxed warnings: respiratory depression when combined with opioids, significant withdrawal risks upon abrupt cessation, and potential for abuse. Adverse effects are dose-dependent, ranging from sedation and ataxia to rare but severe skin reactions like Stevens-Johnson syndrome, which are linked to specific genetic variations. Therapeutic monitoring involves tracking trough concentrations, typically between 10 and 40 micrograms per milliliter, alongside periodic assessments of liver function, blood counts, and vitamin levels, including folate and vitamin D. Because phenobarbital acts as a potent CYP3A4 enzyme inducer, it significantly alters the metabolism of numerous medications, such as amiodarone and various anticoagulants, necessitating rigorous drug interaction screening to ensure patient safety and maintain therapeutic efficacy.